MiddleBrook Pharmaceuticals Schedules Third Quarter 2009 Results Conference Call and Webcast
15 October 2009 - 11:07PM
Business Wire
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is scheduled to
announce its results for the 2009 third quarter on Thursday, Nov.
5, 2009, before the market opens. At 9:00 a.m. (ET) on that day,
MiddleBrook management will conduct a conference call to review
results for the 2009 third quarter.
To listen live to the call, dial 1-800-813-8504 or
1-660-422-4526. A replay of the call will be available starting at
approximately 11 a.m. on Nov. 5 through 5 p.m. on Nov. 12, 2009. To
listen to the replay, dial 1-800-642-1687 or 1-706-645-9291, and
enter the conference ID #36178550.
A live audio webcast of the conference call also will be
available by going to the Investor Relations section of
MiddleBrook's web site, www.middlebrookpharma.com. A replay of the
webcast will be available for approximately one year starting the
afternoon of Nov. 6, 2009.
About MiddleBrook
Pharmaceuticals:
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a
pharmaceutical company focused on developing and commercializing
anti-infective products that fulfill unmet medical needs.
MiddleBrook’s proprietary delivery technology—PULSYS—enables the
pulsatile delivery, or delivery in rapid bursts, of certain drugs.
MiddleBrook’s near-term corporate strategy includes improving
dosing regimens and/or reducing frequency of dosing to enhance
patient dosing convenience and compliance for antibiotics that have
been used and trusted by physicians and patients for decades.
MiddleBrook currently markets KEFLEX (cephalexin, USP), the
immediate-release brand of cephalexin, and MOXATAG–the first and
only FDA-approved once-daily amoxicillin. For more information
about MiddleBrook, please visit www.middlebrookpharma.com.
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
Historical Stock Chart
From Apr 2024 to May 2024
Middlebrook Pharmaceuticals (MM) (NASDAQ:MBRK)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Middlebrook Pharmaceuticals (MM) (NASDAQ): 0 recent articles
More MiddleBrook Pharmaceuticals, Inc. News Articles